TPP1 and non-small cell lung carcinoma: Expression levels of RAP1 and TPP1 were significantly lower in advanced NSCLC cases (median NCN: 11.65 vs. 30.74; p = 0.0020 and 33.7 vs. 106.3; p = 0.012, respectively).